Maryland Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Healthcare Reporter.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on September 17, 2025

September 17, 2025

From Sand to Spotlight: Volleyball Star Bourne Turns Battle with Rare Disease into National Honor for Myositis Awareness

EIN Presswire

September 17, 2025

Leap Orbit Launches 'PDMP Access for All': RxConnections Pilot Program for Rural Health Systems in Kentucky and Illinois

EIN Presswire

September 17, 2025

Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study

GlobeNewswire

September 17, 2025

Bionano Genomics, Inc. Announces Closing of $10 Million Public Oﬀering

GlobeNewswire

September 17, 2025

Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation

GlobeNewswire

September 17, 2025

Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe

GlobeNewswire

September 17, 2025

NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1

GlobeNewswire

September 17, 2025

NANOBIOTIX annonce de nouveaux résultats de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-PD-1

GlobeNewswire

September 17, 2025

Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM

GlobeNewswire

September 17, 2025

Regional Health Properties, Inc. Completes Repurchases of 12.5% Series B Cumulative Redeemable Preferred Shares

GlobeNewswire

September 17, 2025

Vaxart Appoints W. Mark Watson as Lead Independent Director

GlobeNewswire

September 17, 2025

Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update

GlobeNewswire

September 17, 2025

Joint Commission and Coalition for Health AI (CHAI) Release Initial Guidance to Support Responsible AI Adoption Across U.S. Health Systems

GlobeNewswire

September 17, 2025

Buying Guide to the Top & Most Effective Beetroot Supplements 2025: Pills and Powder By MushCanyon

GlobeNewswire

September 17, 2025

Joint Commission Announces 2025 Quality and Patient Safety Award Winners

GlobeNewswire

September 17, 2025

Global Patient Monitoring Devices Market to Cross USD 110 Billion Mark by 2032 | DelveInsight

GlobeNewswire

September 17, 2025

The Association of American Physicians and Surgeons (AAPS) Supports HHS Secretary Kennedy and Making America Healthy Again (MAHA)

GlobeNewswire

September 17, 2025

Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge

GlobeNewswire

September 17, 2025

FMOL Health Shows Drastic Reduction in Sepsis Related Deaths

GlobeNewswire

September 17, 2025

2025 Buyer’s Guide - Best Lion’s Mane Supplement — deep research, how it works, benefits, safety, and product picks why MushCanyon

GlobeNewswire